Title
Subscribe to the Magazine for free
Subscribe for free to keep reading! If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.

Understanding Specialized Pro-Resolving Lipid Mediators

Why This Was Updated?

Our specialists regularly review advancements in health and wellness, ensuring our articles are updated with the newest information as it becomes accessible.
Medically Reviewed by

When we get injured, infected, or exposed to harmful substances, the immune system springs into action, creating inflammation to isolate and neutralize the threat. The inflammation is usually transient. However, lingering inflammation can contribute to long-term damage, leading to heart disease, arthritis, or even cancer.Β 

This is where specialized pro-resolving lipid mediators (SPMs) come into play. SPMs are bioactive lipids, derived mainly from omega-3 fatty acids, that resolve inflammation. Unlike conventional anti-inflammatory drugs, SPMs help the body clear away the inflammatory mess without disrupting immune function. This article provides an overview of SPMs, their mechanism of action, and their benefits.

[signup]

Types of Specialized Pro-Resolvi ng Lipid Mediators

There are several families of SPMs, each with a distinct role in the inflammation resolution process. These mediators work like highly specialized teams that address different aspects of inflammation throughout the body. Let’s dive into the three main categories:

1. Eicosanoids

Eicosanoids are derived from both omega-3 and omega-6 fatty acids and serve various roles in inflammation and immune regulation. While some eicosanoids are pro-inflammatory, specific ones within the SPM family help shut down inflammation.

Example:

2. Docosanoids

Docosanoids are derived from docosahexaenoic acid (DHA), another omega-3 fatty acid in high amounts in the brain, eyes, and heart. These mediators help resolve inflammation in organs especially vulnerable to chronic inflammation.

Examples:

3. Lipoxins

Lipoxins are unique because they are derived from omega-6 fatty acids like arachidonic acid. Omega-6 fatty acids are typically associated with promoting inflammation, but lipoxins balance this process by helping resolve it.

Example:

  • Lipoxin A4 and B4: These molecules act as a "brake" on inflammation by preventing neutrophils from accumulating in large numbers at the injury site. Lipoxin A4, for instance, helps promote the clearance of neutrophils from inflamed tissues, allowing the inflammation to wind down without compromising the immune response.Β 
  • This dual action makes lipoxins particularly valuable in resolving inflammation while allowing the immune system to function effectively.

Mechanisms of Action

SPMs function through a complex system of signaling pathways that tell immune cells to switch from β€œattack mode" to "cleanup mode."

Inflammation Resolution Pathways

SPMs signal immune cells such as macrophages to "eat" and remove debris from injured tissues, including dead cells, bacteria, and other inflammatory waste. This cleanup phase is critical because leftover debris can perpetuate a low-grade, chronic inflammatory response, leading to longer-term tissue damage.

Receptor Engagement

Each type of SPM interacts with specific receptors on immune cells to trigger these actions. For example:

Clinical Implications and Applications

The potential of SPMs goes far beyond their role in day-to-day inflammation. They hold significant promise for chronic inflammatory diseases, where persistent, unresolved inflammation drives disease progression.

Role in Chronic Inflammatory Diseases

Unresolved inflammation is a central feature of many chronic diseases, from rheumatoid arthritis to asthma and cardiovascular conditions. Here’s how SPMs might help:

  • Rheumatoid arthritis (RA): In RA, the immune system mistakenly attacks the joints, causing inflammation and pain. SPMs could offer a targeted approach by reducing inflammation and actively resolving it, helping protect joint tissue from further damage.
  • Asthma: Chronic airway inflammation is a hallmark of asthma. SPMs like resolvins have been shown to help reduce airway inflammation, making them a promising tool for managing severe asthma attacks.

Potential Therapeutic Uses

SPMs are being explored as potential therapies for these chronic conditions. Unlike nonsteroidal anti-inflammatory drugs (NSAIDs), which can suppress the immune response and lead to side effects like gastrointestinal issues, SPMs work naturally with the body’s healing mechanisms. They help resolve inflammation without shutting down the body’s defense systems.

Studies have shown that SPMs can help reduce the buildup of plaques in arteries in cardiovascular disease, suggesting a role in preventing heart attacks and strokes. Early clinical trials are exploring how SPM-based therapies might be used to manage inflammation in a more targeted and long-term way.

Diagnostic and Therapeutic Approaches

Clinicians can measure SPM levels in blood, tissue, and other fluids to gauge how well the body resolves inflammation. This can provide insights into a patient’s overall inflammation status, helping doctors decide whether SPM therapy might be beneficial.

One commonly used method is liquid chromatography-mass spectrometry (LC-MS), a highly accurate tool for measuring SPM concentrations. By understanding a patient’s SPM levels, clinicians can tailor treatments to boost their body’s natural inflammation-resolving pathways.

Therapeutic Strategies

There are several ways to enhance SPM levels in the body, both naturally and through supplementation:

  • SPM supplements: Available as pills or oils derived from omega-3-rich sources like fish oil, SPM supplements are being studied for their effectiveness in reducing chronic inflammation.
  • Dietary sources: Increasing the intake of omega-3 fatty acids from foods like fatty fish (salmon, sardines), flaxseeds, and walnuts can help boost the body’s natural production of SPMs.

Challenges and Future Directions

While research on SPMs is promising, there are still gaps in our understanding. For example, we don’t fully know how different people might produce or respond to SPMs, which could affect how well SPM-based therapies work for each individual. Additionally, the best ways to deliver SPMs in therapeutic doses remain a topic of ongoing research.

Emerging Trends

One exciting area of SPM research is personalized medicine. Clinicians can tailor treatments to optimize the body’s resolution pathways by studying a patient's unique inflammatory profile. Moreover, developing synthetic SPMsβ€”designed to mimic or enhance the effects of natural SPMsβ€”could offer more potent and reliable therapeutic options in the future.

[signup]Β 

Key Takeaways:

  • SPMs: These bioactive lipids play a crucial role in resolving inflammation naturally without suppressing immune function.
  • Types of SPMs: Include eicosanoids, docosanoids, and lipoxins, each targeting different types of inflammation and immune responses.
  • How SPMs Work: By binding to specific receptors on immune cells, SPMs trigger the cleanup of inflammation-related debris and promote healing.
  • Clinical Applications: SPMs show promise in treating chronic inflammatory diseases, such as rheumatoid arthritis, asthma, and cardiovascular conditions.
  • Therapeutic Approaches: SPMs can be boosted through supplements or increased consumption of omega-3-rich foods.
  • Future Directions: Continued research on synthetic SPMs and personalized medicine may lead to more targeted treatments for inflammation-related diseases.
  • Why It Matters: Understanding SPMs offers a more holistic, proactive approach to managing chronic diseases by focusing on clearing inflammation rather than merely suppressing it.
The information provided is not intended to be a substitute for professional medical advice. Always consult with your doctor or other qualified healthcare provider before taking any dietary supplement or making any changes to your diet or exercise routine.
Learn More
No items found.

Lab Tests in This Article

No lab tests!

A Papayianni, Serhan, C. N., & Brady, H. R. (1996). Lipoxin A4 and B4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells. The Journal of Immunology, 156(6), 2264–2272. https://doi.org/10.4049/jimmunol.156.6.2264

Achuff, J. (2024, March 11). https://www.rupahealth.com/post/the-hidden-aftermath-of-heart-attacks-a-comprehensive-study-unveils-increased-risks. Rupa Health. https://www.rupahealth.com/post/the-hidden-aftermath-of-heart-attacks-a-comprehensive-study-unveils-increased-risks

Bannenberg, G., & Serhan, C. N. (2010). Specialized pro-resolving lipid mediators in the inflammatory response: An update. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1801(12), 1260–1273. https://doi.org/10.1016/j.bbalip.2010.08.002

Bazan, N. G. (2018). Docosanoids and elovanoids from omega-3 fatty acids are pro-homeostatic modulators of inflammatory responses, cell damage and neuroprotection. Molecular Aspects of Medicine, 64, 18–33. https://doi.org/10.1016/j.mam.2018.09.003

Bigman, S. (2024, May 30). The truth about fish oil supplements: Benefits, risks, and controversies. Rupa Health. https://www.rupahealth.com/post/the-truth-about-fish-oil-supplements-benefits-risks-and-controversies

Blake, K. (2023, December 15). The Power of Functional Foods in Cancer Prevention. Rupa Health. https://www.rupahealth.com/post/the-power-of-functional-foods-in-cancer-prevention

Brash, A. R. (2001). Arachidonic acid as a bioactive molecule. Journal of Clinical Investigation, 107(11), 1339–1345. https://doi.org/10.1172/jci13210

Bryant, A. (2024, September 24). Symptoms of Rheumatoid Arthritis: Recognizing the Early Signs. Rupa Health. https://www.rupahealth.com/post/symptoms-of-rheumatoid-arthritis-recognizing-the-early-signs

Calder, P. C. (2010). Omega-3 Fatty Acids and Inflammatory Processes. Nutrients, 2(3), 355–374.

Calder, P. C. (2016). Docosahexaenoic Acid. Annals of Nutrition and Metabolism, 69(1), 8–21. https://doi.org/10.1159/000448262

Callan, N., Hanes, D., & Bradley, R. (2020). Early evidence of efficacy for orally administered SPM-enriched marine lipid fraction on quality of life and pain in a sample of adults with chronic pain. Journal of Translational Medicine, 18(1). https://doi.org/10.1186/s12967-020-02569-5

Chandrasekharan, J. A., & Sharma-Walia, N. (2015). Lipoxins: nature’s way to resolve inflammation. Journal of Inflammation Research, 8, 181–192. https://doi.org/10.2147/JIR.S90380

Chiang, N., Barnaeva, E., Hu, X., Marugan, J., Southall, N., Ferrer, M., & Serhan, C. N. (2019). Identification of Chemotype Agonists for Human Resolvin D1 Receptor DRV1 with Pro-Resolving Functions. Cell Chemical Biology, 26(2), 244-254.e4. https://doi.org/10.1016/j.chembiol.2018.10.023

ChiurchiΓΉ, V., Leuti, A., Dalli, J., Jacobsson, A., Battistini, L., Maccarrone, M., & Serhan, C. N. (2016). Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses. Science Translational Medicine, 8(353). https://doi.org/10.1126/scitranslmed.aaf7483

ClΓ ria, J., Dalli, J., Yacoubian, S., Gao, F., & Serhan, C. N. (2012). Resolvin D1 and Resolvin D2 Govern Local Inflammatory Tone in Obese Fat. The Journal of Immunology, 189(5), 2597–2605. https://doi.org/10.4049/jimmunol.1201272

Cloyd, J. (2023a, April 14). How to alleviate gastrointestinal (GI) symptoms naturally without medication. Rupa Health. https://www.rupahealth.com/post/how-to-alleviate-gastrointestinal-gi-symptoms-naturally-without-medication

Cloyd, J. (2023b, May 17). The Role Of Nutrition And Dietary Supplements In Preventing And Managing Cardiovascular Disease. Rupa Health. https://www.rupahealth.com/post/the-role-of-nutrition-and-dietary-supplements-in-preventing-and-managing-cardiovascular-disease

Cloyd, J. (2023c, June 19). A Functional Medicine Post Stroke Protocol: Testing, Therapeutic Diet, and Integrative Therapy Options. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-post-stroke-protocol-testing-supplements-and-integrative-therapy-options

Cloyd, J. (2023d, October 18). The 6 Most Important Uses of Omega-3s For Your Health. Rupa Health. https://www.rupahealth.com/post/the-6-most-important-uses-of-omega-3s-for-your-health

Cloyd, J. (2024, September 9). What Does a High White Blood Cell Count Mean? Causes, Testing, and Health Implications. Rupa Health. https://www.rupahealth.com/post/what-does-a-high-white-blood-cell-count-mean-causes-testing-and-health-implications

Coras, R., Kavanaugh, A., Boyd, T., Huynh, Q., Pedersen, B., Armando, A. M., Dahlberg-Wright, S., Marsal, S., Jain, M., Paravar, T., Quehenberger, O., & Guma, M. (2019). Pro- and anti-inflammatory eicosanoids in psoriatic arthritis. Metabolomics, 15(4). https://doi.org/10.1007/s11306-019-1527-0

Dalli, J., Gomez, E. A., & Jouvene, C. C. (2022). Utility of the Specialized Pro-Resolving Mediators as Diagnostic and Prognostic Biomarkers in Disease. Biomolecules, 12(3), 353–353. https://doi.org/10.3390/biom12030353

DePorto, T. (2022, December 9). Worried About Heart Disease? Ask Your Provider for These 6 Specialty Labs at Your Next Appointment. Rupa Health. https://www.rupahealth.com/post/worried-about-heart-disease-ask-your-provider-for-these-6-specialty-labs-at-your-next-appointment

Duvall, M. G., & Levy, B. D. (2016). DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation. European Journal of Pharmacology, 785, 144–155. https://doi.org/10.1016/j.ejphar.2015.11.001

El Kebir, D., Gjorstrup, P., & Filep, J. G. (2012). Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation. Proceedings of the National Academy of Sciences, 109(37), 14983–14988. https://doi.org/10.1073/pnas.1206641109

Fredman, G., & Saba Khursheed Khan. (2023). Specialized pro‐resolving mediators enhance the clearance of dead cells. Immunological Reviews. https://doi.org/10.1111/imr.13278

Gerow, S. (2024, July 2). Understanding the Role of Omega-3s in Fighting Inflammation. Rupa Health. https://www.rupahealth.com/post/the-role-of-omega-3s-in-fighting-inflammation

Harwood, J. L. (2023). Polyunsaturated Fatty Acids: Conversion to Lipid Mediators, Roles in Inflammatory Diseases and Dietary Sources. International Journal of Molecular Sciences, 24(10), 8838. https://doi.org/10.3390/ijms24108838

Hasturk, H., Kantarci, A., Goguet-Surmenian, E., Blackwood, A., Andry, C., Serhan, C. N., & Van Dyke, T. E. (2007). Resolvin E1 Regulates Inflammation at the Cellular and Tissue Level and Restores Tissue Homeostasis In Vivo. The Journal of Immunology, 179(10), 7021–7029. https://doi.org/10.4049/jimmunol.179.10.7021

HernΓ‘ndez-Dı́azS., & Garcı́a-Rodrı́guezL. A. (2001). Epidemiologic assessment of the safety of conventional nonsteroidal anti-inflammatory drugs. The American Journal of Medicine, 110(3), 20–27. https://doi.org/10.1016/s0002-9343(00)00682-3

Hodges, R. R., Li, D., Shatos, M. A., Bair, J. A., Lippestad, M., Serhan, C. N., & Dartt, D. A. (2016). Lipoxin A4 activates ALX/FPR2 receptor to regulate conjunctival goblet cell secretion. Mucosal Immunology, 10(1), 46–57. https://doi.org/10.1038/mi.2016.33

Innes, J. K., & Calder, P. C. (2018). Omega-6 fatty acids and inflammation. Prostaglandins, Leukotrienes and Essential Fatty Acids, 132, 41–48. https://doi.org/10.1016/j.plefa.2018.03.004

Janssen, W. J., & Henson, P. M. (2011). Cellular Regulation of the Inflammatory Response. Toxicologic Pathology, 40(2), 166–173. https://doi.org/10.1177/0192623311428477

JΓ³nasdΓ³ttir, H. S., Andreea Ioan-Facsinay, Joanneke Kwekkeboom, Brouwers, H., Anne-Marie Zuurmond, RenΓ© Toes, Deelder, A. M., & Giera, M. (2014). An Advanced LC–MS/MS Platform for the Analysis of Specialized Pro-Resolving Lipid Mediators. Chromatographia, 78(5-6), 391–401. https://doi.org/10.1007/s10337-014-2779-5

Katona, P., & Katona‐Apte, J. (2008). The Interaction between Nutrition and Infection. Clinical Infectious Diseases, 46(10), 1582–1588. https://doi.org/10.1086/587658

Khakham, C. (2023a, April 6). Understanding Your Risk of Cardiovascular Disease With Functional Medicine Labs. Rupa Health. https://www.rupahealth.com/post/understanding-your-risk-of-cardiovascular-disease-with-functional-medicine-labs

Khakham, C. (2023b, July 10). Understanding Environmental Toxins and Their Impact on Health. Rupa Health. https://www.rupahealth.com/post/understanding-environmental-toxins-and-their-impact-on-health

Khakham, C. (2023c, July 11). Integrative medicine approach to asthma: Testing, dietary interventions, and natural remedies. Rupa Health. https://www.rupahealth.com/post/integrative-medicine-approach-to-asthma-testing-dietary-interventions-and-natural-remedies

Kim, A. S., & Conte, M. S. (2020). Specialized pro-resolving lipid mediators in cardiovascular disease, diagnosis, and therapy. Advanced Drug Delivery Reviews. https://doi.org/10.1016/j.addr.2020.07.011

Langley, J. (2004). What is an injury? Injury Prevention, 10(2), 69–71. https://doi.org/10.1136/ip.2003.003715

Lazzell, K. (2023, September 29). Melanie’s Journey to Conquering Asthma Naturally – A Case Study Using Root Cause Medicine for Pediatric Respiratory Wellness. Rupa Health. https://www.rupahealth.com/post/melanies-journey-to-conquering-asthma-naturally-a-case-study-in-holistic-healing-for-pediatric-respiratory-wellness

Leuti, A., Fazio, D., Fava, M., Piccoli, A., Oddi, S., & Maccarrone, M. (2020). Bioactive lipids, inflammation and chronic diseases. Advanced Drug Delivery Reviews, 159, 133–169. https://doi.org/10.1016/j.addr.2020.06.028

Liu, G., Tao, T., Wang, H., Zhou, Y., Gao, X., Gao, Y., Hang, C.-H., & Li, W. (2020). Functions of resolvin D1-ALX/FPR2 receptor interaction in the hemoglobin-induced microglial inflammatory response and neuronal injury. Journal of Neuroinflammation, 17(1). https://doi.org/10.1186/s12974-020-01918-x

Maddox, J. F., Colgan, S. P., Clish, C. B., Petasis, N. A., Fokin, V. V., & Serhan, C. N. (1998). Lipoxin B4regulates human monocyte/neutrophil adherence and motility: design of stable lipoxin B4analogs with increased biologic activity. The FASEB Journal, 12(6), 487–494. https://doi.org/10.1096/fasebj.12.6.487

MΓΆller, I., Rodas, G., Jose MarΓ­a VillalΓ³n, Rodas, J. A., Angulo, F., MartΓ­nez, N., & Josep VergΓ©s. (2023). Randomized, double-blind, placebo-controlled study to evaluate the effect of treatment with an SPMs-enriched oil on chronic pain and inflammation, functionality, and quality of life in patients with symptomatic knee osteoarthritis: GAUDI study. Journal of Translational Medicine, 21(1). https://doi.org/10.1186/s12967-023-04283-4

Natami, M., Seyed Mehdi Hosseini, Raghad Abdulsalam Khaleel, Tamara Shamil Addulrahman, Mehdi Zarei, Asadi, S., Gholami, S., & Amir Mehrvar. (2024). The role of specialized pro-resolving mediators (SPMs) in inflammatory arthritis: A therapeutic strategy. Prostaglandins & Other Lipid Mediators, 170, 106798–106798. https://doi.org/10.1016/j.prostaglandins.2023.106798

Recchiuti, A. (2013). Resolvin D1 and its GPCRs in resolution circuits of inflammation. Prostaglandins & Other Lipid Mediators, 107, 64–76. https://doi.org/10.1016/j.prostaglandins.2013.02.004

Recchiuti, A., & Serhan, C. N. (2012). Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation. Frontiers in Immunology, 3. https://doi.org/10.3389/fimmu.2012.00298

Regidor, P.-A., Mueller, A., Sailer, M., Gonzalez Santos, F., Rizo, J. M., & Moreno Egea, F. (2020). Chronic Inflammation in PCOS: The Potential Benefits of Specialized Pro-Resolving Lipid Mediators (SPMs) in the Improvement of the Resolutive Response. International Journal of Molecular Sciences, 22(1), 384. https://doi.org/10.3390/ijms22010384

Schaldach, C. M., Riby, J., & Bjeldanes, L. F. (1999). Lipoxin A4: A New Class of Ligand for the Ah Receptor. Biochemistry, 38(23), 7594–7600. https://doi.org/10.1021/bi982861e

Schmid-SchΓΆnbein, G. W. (2006). ANALYSIS OF INFLAMMATION. Annual Review of Biomedical Engineering, 8(1), 93–151. https://doi.org/10.1146/annurev.bioeng.8.061505.095708

Schwab, J. M., Chiang, N., Arita, M., & Serhan, C. N. (2007). Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature, 447(7146), 869–874. https://doi.org/10.1038/nature05877

Serhan, C. N. (2014). Pro-resolving lipid mediators are leads for resolution physiology. Nature, 510(7503), 92–101. https://doi.org/10.1038/nature13479

Serhan, C. N., & Levy, B. D. (2018). Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators. Journal of Clinical Investigation, 128(7), 2657–2669. https://doi.org/10.1172/jci97943

Serhan, C. N., Libreros, S., & Nshimiyimana, R. (2022). E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition. Seminars in Immunology, 59, 101597. https://doi.org/10.1016/j.smim.2022.101597

Serhan, C. N., & Petasis, N. A. (2011). Resolvins and Protectins in Inflammation Resolution. Chemical Reviews, 111(10), 5922–5943. https://doi.org/10.1021/cr100396c

Silva, J. R., Burger, B., KΓΌhl, C. M. C., Candreva, T., dos Anjos, M. B. P., & Rodrigues, H. G. (2018). Wound Healing and Omega-6 Fatty Acids: From Inflammation to Repair. Mediators of Inflammation, 2018, 1–17. https://doi.org/10.1155/2018/2503950

Simopoulos, A. P. (2002). The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomedicine & Pharmacotherapy, 56(8), 365–379. https://doi.org/10.1016/s0753-3322(02)00253-6

Smith, W. L. (1989). The eicosanoids and their biochemical mechanisms of action. Biochemical Journal, 259(2), 315–324. https://doi.org/10.1042/bj2590315

Stanford, J. (2024, June 20). NSAIDs Fact Sheet: Uses, Benefits, Risks, and More. Rupa Health. https://www.rupahealth.com/post/nsaids-fact-sheet

Stark, K. D., Van Elswyk, M. E., Higgins, M. R., Weatherford, C. A., & Salem, N. (2016). Global survey of the omega-3 fatty acids, docosahexaenoic acid and eicosapentaenoic acid in the blood stream of healthy adults. Progress in Lipid Research, 63, 132–152. https://doi.org/10.1016/j.plipres.2016.05.001

Viola, J., & Soehnlein, O. (2015). Atherosclerosis – A matter of unresolved inflammation. Seminars in Immunology, 27(3), 184–193. https://doi.org/10.1016/j.smim.2015.03.013

Weinberg, J. (2022, July 26). 5 Things You Can Do To Find Relief For Arthritis. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-approach-to-osteoarthritis

Wu, B., Walker, J., B. Spur, Rodriguez, A., & Yin, K. (2014). Effects of Lipoxin A4 on antimicrobial actions of neutrophils in sepsis. Prostaglandins Leukotrienes and Essential Fatty Acids, 94, 55–64. https://doi.org/10.1016/j.plefa.2014.11.005

Yoshimura, H. (2023, October 10). A Root Cause Medicine Approach to Chronic Inflammation. Rupa Health. https://www.rupahealth.com/post/a-root-cause-medicine-approach-to-chronic-inflammation

Zahoor, I., & Giri, S. (2021). Specialized Pro-Resolving Lipid Mediators: Emerging Therapeutic Candidates for Multiple Sclerosis. Clinical Reviews in Allergy & Immunology, 60(2), 147–163. https://doi.org/10.1007/s12016-020-08796-4

Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
See All Magazine Articles
Trusted Source
Rupa Health
Medical Education Platform
Visit Source
American Cancer Society
Foundation for Cancer Research
Visit Source
National Library of Medicine
Government Authority
Visit Source
Journal of The American College of Radiology
Peer Reviewed Journal
Visit Source
National Cancer Institute
Government Authority
Visit Source
World Health Organization (WHO)
Government Authority
Visit Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
CDC
Government Authority
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
National Institutes of Health
Government Authority
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Brain
Peer Reviewed Journal
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
Chest
Peer Reviewed Journal
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source